Bevespi Aerosphere

Active Ingredient(s): Glycopyrrolate + Formoterol Fumarate
FDA Approved: * April 25, 2016
Pharm Company: * PEARL THERAPEUTICS INC
Category: Lungs (Pulmonary)

Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12h) compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4h to 6h. LABAs such as formoterol are used as "symptom controllers" to supplement prophylactic corticosteroid therapy. A "reliever" short-acting β2 agoni... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Bevespi Aerosphere Respiratory (Inhalation) Aerosol, Metered
NDC: 0310-4600
Labeler:
Astrazeneca Pharmaceuticals Lp

Popular Topics

Bevespi Aerosphere Reviews

I was just given this relatively new drug today called Bevespi Aerosphere. I have stage 4 emphysema. Wondering if anyone...

1 REPLY